Literature DB >> 23420312

[3-year follow-up after endovascular aneurysm treatment with Silk® flow diverter].

A Ringelstein1, M Schlamann, S L Goericke, C Mönninghoff, I E Sandalcioglu, N El Hindy, M Forsting, I Wanke.   

Abstract

PURPOSE: Flow diverters may occlude aneurysms by endoluminal reconstruction of the parent artery and by reducing the blood flow into the aneurysm. The purpose of this study was to assess the rate of intervention-associated complications and a 3-year-follow-up.
MATERIALS AND METHODS: We retrospectively analyzed 18 patients treated with Silk® FD. Only patients with unruptured aneurysms were included. Treatment indications were fusiform, giant or recurrent aneurysms. We considered all aneurysms to have a high likelihood of failure and/or recurrence when treated with conventional endovascular techniques.
RESULTS: Silk FD could directly be placed in a proper position across the whole length of the aneurysm in 16/18 patients. In one case an additional PTA was necessary. In another case the first FD could not be properly deployed. 17 of 18 aneurysms (95 %) were occluded immediately, in the mid-term follow-up after 6 months or 3 years after treatment. The overall complication rate including technical (11.1 %), acute or delayed thromboembolic complication without (11.1 %) or with (16.6 %) severe complications was documented.
CONCLUSION: FD treatment is effective with a high occlusion rate of aneurysms also in long-term follow-up. In these complex aneurysms the complication rate is higher than in conventional stent-assisted coiling. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23420312     DOI: 10.1055/s-0032-1330353

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

Review 1.  Design and biocompatibility of endovascular aneurysm filling devices.

Authors:  Jennifer N Rodriguez; Wonjun Hwang; John Horn; Todd L Landsman; Anthony Boyle; Mark A Wierzbicki; Sayyeda M Hasan; Douglas Follmer; Jesse Bryant; Ward Small; Duncan J Maitland
Journal:  J Biomed Mater Res A       Date:  2014-08-04       Impact factor: 4.396

2.  In Vitro Evaluation of Intra-Aneurysmal, Flow-Diverter-Induced Thrombus Formation: A Feasibility Study.

Authors:  K Gester; I Lüchtefeld; M Büsen; S J Sonntag; T Linde; U Steinseifer; G Cattaneo
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-08       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.